Redefining First-Line HER2-Positive Advanced Gastric Cancer: From Trastuzumab-Based Chemoimmunotherapy to Zanidatamab and Next-Generation HER2 Targeting

Journal of Gastrointestinal Cancer · Published 2026-08-05 · DOI 10.1007/s12029-026-01560-5

Authors (4)

Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, Koshi Fujikawa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sagawa, T., Hirakawa, M., Nagashima, H., et al. (2026). Redefining First-Line HER2-Positive Advanced Gastric Cancer: From Trastuzumab-Based Chemoimmunotherapy to Zanidatamab and Next-Generation HER2 Targeting. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-026-01560-5

Related articles

• A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines: 2024 Update · Journal of Gastric Cancer · 2025 · Cites or is cited by this article
• Characteristics and Outcomes of Patients With Malignancies Prior to Colorectal Cancer: A Propensity Score Matched Analysis · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: a Single-Center Retrospective Study · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981–2021 · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Factors Associated with Improved Survival for Stage I and II Pancreatic Adenocarcinoma Utilizing the National Cancer Database · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Access or Engagement: The Potential Role of Financial Incentives in Colorectal Cancer Screening · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Comment on “Efficacy of Radiotherapy Combined with Immunotherapy in MSS/pMMR Metastatic Colorectal Cancer: A Propensity-Matched Retrospective Study” · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Safety of Immune-Targeted Therapy in Patients with Hepatocellular Carcinoma in the Real-World · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection · Journal of Gastrointestinal Cancer · 2026 · Same journal
• Gastric Cancer Incidence in Iran: Trends and Projections to 2030 based on Global Burden of Disease 2021 Estimates · Journal of Gastrointestinal Cancer · 2026 · Same journal